查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1808303

医疗保健分析测试服务市场（按测试类型、技术类型、样本类型、应用和最终用户划分）—2025 年至 2030 年全球预测

Healthcare Analytical Testing Services Market by Testing Type, Technology Type, Sample Type, Application, End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 189 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计医疗分析测试服务市场规模到 2024 年将达到 92.8 亿美元，到 2025 年将达到 103 亿美元，到 2030 年将达到 177.9 亿美元，复合年增长率为 11.44%。

主要市场统计数据
基准年2024年 92.8亿美元
预计2025年 103亿美元
预测年份 2030 177.9亿美元
复合年增长率（%） 11.44%

探索医疗保健分析测试服务的发展动态以及影响未来市场发展的新需求驱动因素

医疗保健分析检测服务是现代医学诊断、药物研发和法医学调查的基石。随着临床实验室、受託研究机构和学术机构努力满足日益严格的品质标准，对复杂调查方法的需求也日益增长。这些服务涵盖了一系列旨在检测、定量和表征临床样本中生物和化学因子的技术。透过确保准确性、可重复性和合规性，分析检测能够保障病人安全，支持实证决策，并推动整个医疗保健领域的创新。

透过技术创新和不断变化的监管环境，揭示重新定义医疗保健检测格局的重大变革

在样本处理、分析仪器和生物资讯学领域取得突破的推动下，医疗保健分析检测生态系统正在经历一场变革性的復兴。随着实验室不断追求更高的灵敏度和特异性，微流体平台和自动化样品处理系统的采用正在扩大操作通量，同时减少样品量和试剂浪费。这种模式转移使实验室能够快速应对疫情，以前所未有的精度监测治疗性生物标记物，并即时支持药物动力学研究。

评估2025年美国关税对医疗分析测试成本结构和营运策略的综合累积影响

2025年，美国修订后的关税生效，为医疗分析检测供应商及其供应链带来了新的复杂性。来自主要製造地的多种关键试剂、仪器组件和专用耗材的成本正在逐步上涨。这些调整对单点实验室和多点实验室网路的服务定价模式、营运预算和资本支出计画产生了下游影响。此外，其对全球经销商的连锁反应使其必须重新评估库存策略，以降低关税波动带来的风险。

揭示医疗保健分析测试在测试类型、技术、样本、应用程式和最终用户方面的关键细分趋势

医疗保健分析测试可以透过测试类型来理解。定性服务包括旨在快速目测或比色反应的抽检测试，以及用于确认样品完整性的详细目视检测通讯协定。相较之下，定量服务则依赖免疫测量来定量高特异性的生物标记物，并利用仪器分析技术利用光谱讯号和质荷比进行精确的浓度测量。这种双重方法既能确保即时的筛检能力，又能确保全面的定量检验。

介绍美洲、欧洲、中东和非洲以及亚太地区医疗分析测试市场动态的关键区域见解

区域动态在塑造全球医疗保健分析检测格局方面发挥关键作用，因为不同地区不断变化的法律规范、基础设施能力和投资模式存在显着差异。拉丁美洲的新兴经济体正优先考虑实验室能力的扩展和技能的培养，以加强公共卫生监测网络。

重点介绍推动全球医疗分析测试服务创新的主要企业的策略性倡议和竞争格局

医疗保健分析检测服务领域由许多知名实验室、创新服务供应商和专业技术供应商组成。领先的开发商凭藉整合高通量筛检、先进生物资讯学和客製化检测开发等技术的综合服务组合，脱颖而出。这些先驱企业对专有试剂组、实验室自动化和数数位资料平台的策略性投资，使其能够提供标准化且灵活的解决方案，满足广泛的临床和研究应用频谱。

向行业领导者提供可行的建议，以加强竞争并推动医疗分析测试服务的成长。

产业领导者必须优先投资数位转型，以保持竞争优势和营运效率。整合云端基础的资料管理、人工智慧分析和远端监控功能，可显着缩短週转时间，增强可追溯性，并支援可扩展的实验室网路。与软体开发人员和生物资讯学专家建立伙伴关係，可以将新兴技术无缝融入现有工作流程。

详细阐述了用于全面分析医疗分析测试服务趋势和市场驱动因素的严格调查方法

本分析的研究基础是透过系统性的多阶段方法建立的，包括收集一手和二手研究资料、严格的检验通讯协定以及专家咨询。首先，进行了广泛的文献综述，包括同行评审日誌、监管指南和行业白皮书，以了解基本趋势并识别新兴技术。这一二次研究阶段为假设的生成和框架的发展奠定了基础。

综合关键发现和策略要点，帮助相关人员应对不断发展的医疗分析测试服务格局

技术创新、不断变化的监管环境以及不断变化的经济压力正在重塑医疗保健分析检测服务格局。从先进仪器的采用到数据工作流程的数位化，清楚地理解这些变革的相关人员将能够抓住新机会，应对复杂的市场环境。 2025 年的关税调整凸显了韧性供应链和协作筹资策略对于缓解成本波动和维持利润率的重要性。

目录

第一章：前言

第二章调查方法

第三章执行摘要

第四章 市场概述

第五章市场动态

  • 将人工智慧和机器学习演算法整合到临床诊断测试中，以提高准确性和速度
  • 引入与数位健康生态系统整合的就地检验设备，用于即时病患监测
  • 个人化医疗的成长将推动对高通量基因组和蛋白质组检测平台的需求
  • 监理机关越来越重视实验室资讯管理系统对 21 CFR Part 11 的合规性
  • 增加代谢体学分析的投资，用于早期疾病生物标记的发现和预防性医疗保健策略
  • 扩大合约开发和製造组织，提供端到端分析方法开发服务
  • 实施区块链技术，确保临床试验样本和测试结果的安全可追溯性
  • 质谱成像在组织分析中快速应用于空间代谢体学和生物标记定位
  • 需要提供跨基因组学、蛋白质组学和代谢体学数据集的全面见解的多体学数据整合平台
  • 透过开发绿色化学分析方法来减少危险试剂的消耗，并专注于永续性

第六章 市场洞察

  • 波特五力分析
  • PESTEL分析

第七章 2025年美国关税的累积影响

8.医疗保健分析测试服务市场（按测试类型）

  • 定性
    • 抽查
    • 目视检查
  • 定量
    • 免疫检测
    • 仪器分析

9.医疗保健分析测试服务市场（依技术类型）

  • 层析法
    • 气相层析法
    • 液相层析法
  • 质谱法
    • GC-MS
    • LC MS MS
    • MALDI TOF
  • 显微镜
  • PCR
  • 光谱学

第 10 章：医疗保健分析测试服务市场（按样本类型）

  • 血
    • 电浆
    • 血清
    • 全血
  • 组织
  • 尿

第 11 章医疗保健分析测试服务市场（按应用）

  • 临床诊断
    • 基因检测
    • 感染疾病
    • 肿瘤标记
  • 刑事鑑定
    • DNA分析
    • 毒理学
  • 药物测试
    • 生物分析测试
    • 品管

第 12 章：医疗保健分析测试服务市场（按最终用户）

  • 学术研究机构
    • 研究机构
    • 大学
  • 合约研究组织
  • 医院和诊所
    • 医院检查室
    • 病理实验室
  • 製药和生物技术公司

13.美洲医疗保健分析实验室服务市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 阿根廷

14. 欧洲、中东和非洲医疗保健分析实验室服务市场

  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 阿拉伯聯合大公国
  • 沙乌地阿拉伯
  • 南非
  • 丹麦
  • 荷兰
  • 卡达
  • 芬兰
  • 瑞典
  • 奈及利亚
  • 埃及
  • 土耳其
  • 以色列
  • 挪威
  • 波兰
  • 瑞士

15.亚太医疗保健分析实验室服务市场

  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国
  • 印尼
  • 泰国
  • 菲律宾
  • 马来西亚
  • 新加坡
  • 越南
  • 台湾

第十六章竞争格局

  • 2024年市场占有率分析
  • 2024年FPNV定位矩阵
  • 竞争分析
    • Eurofins Scientific SE
    • Laboratory Corporation of America Holdings
    • Almac Group Limited
    • ALS Limited
    • Catalent, Inc.
    • CD Biosciences Inc.
    • Charles River Laboratories International, Inc.
    • Element Materials Technology Group Limited
    • Frontage Laboratories, Inc. by Tigermed
    • ICON PLC
    • Intertek Group PLC
    • IQVIA Holdings Inc.
    • Medpace, Inc.
    • Pace Analytical Services, LLC
    • Pharmaron
    • Piramal Pharma Solutions
    • PPD, Inc.
    • Quest Diagnostics Incorporated
    • Reading Scientific Services Ltd.
    • Sartorius AG
    • SGS SA
    • Thermo Fisher Scientific Inc.
    • WuXi AppTec Co., Ltd.

第十七章 研究人工智慧

第十八章 研究统计

第十九章 研究联络人

第二十章 研究报导

第21章 附录

Product Code: MRR-F949FCDE0EC4

The Healthcare Analytical Testing Services Market was valued at USD 9.28 billion in 2024 and is projected to grow to USD 10.30 billion in 2025, with a CAGR of 11.44%, reaching USD 17.79 billion by 2030.

KEY MARKET STATISTICS
Base Year [2024] USD 9.28 billion
Estimated Year [2025] USD 10.30 billion
Forecast Year [2030] USD 17.79 billion
CAGR (%) 11.44%

Exploring the Evolving Dynamics of Healthcare Analytical Testing Services and the Emerging Demand Drivers Shaping Future Market Developments

Healthcare analytical testing services serve as the cornerstone of modern medical diagnostics, pharmaceutical development, and forensic investigations. As clinical laboratories, contract research organizations, and academic institutions strive to meet increasingly stringent quality standards, the demand for sophisticated testing methodologies has surged. These services encompass a wide array of techniques designed to detect, quantify, and characterize biological and chemical agents in clinical samples. By ensuring accuracy, reproducibility, and regulatory compliance, analytical testing underpins patient safety, supports evidence-based decision-making, and fuels innovation across the healthcare continuum.

Over the past decade, the industry has witnessed a profound evolution driven by technological breakthroughs such as high-resolution mass spectrometry, advanced chromatography platforms, and next-generation sequencing. These innovations have not only expanded the scope of detectable analytes but also accelerated turnaround times, enabling real-time monitoring of biomarkers and therapeutic agents. Furthermore, the integration of digital data management solutions has enhanced traceability, data integrity, and collaborative research efforts. As a result, stakeholders are now better equipped to address complex clinical questions, optimize treatment protocols, and advance personalized medicine initiatives.

In this context, the investment landscape has adapted to foster strategic partnerships between equipment manufacturers, reagent suppliers, and service providers. Such collaborations are fostering the development of end-to-end solutions that streamline sample preparation, analysis, and reporting. This introduction establishes the foundational context for understanding the multifaceted dynamics shaping the healthcare analytical testing sector, setting the stage for a deeper exploration of transformative shifts, regulatory influences, and strategic imperatives.

Uncovering the Major Transformative Shifts Redefining Healthcare Testing Landscapes Through Technological Innovation and Regulatory Advancements

The healthcare analytical testing ecosystem is undergoing a transformative renaissance fueled by breakthroughs in sample processing, analytical instrumentation, and bioinformatics. As laboratories pursue heightened sensitivity and specificity, the adoption of microfluidic platforms and automated sample handling systems has scaled operational throughput while reducing sample volumes and reagent waste. This paradigm shift is empowering laboratories to respond swiftly to outbreaks, monitor therapeutic biomarkers with unprecedented precision, and support pharmacokinetic studies in real time.

Concurrently, the convergence of analytical testing with digital health technologies is redefining stakeholder interactions. Cloud-based data repositories, artificial intelligence-driven analysis pipelines, and blockchain-enabled chain-of-custody solutions are gradually becoming integral components of testing workflows. These digital overlays not only enhance transparency and collaboration between clinicians, researchers, and regulatory bodies but also enable remote assay validation and inter-laboratory proficiency testing on a global scale.

Regulatory landscapes have also adapted to accelerate the validation and deployment of novel analytical methodologies. Agencies are progressively endorsing risk-based approaches, real-world performance data, and harmonized validation protocols, enabling faster time-to-market for critical diagnostic assays. Moreover, the rising emphasis on sustainability has prompted vendors to innovate eco-friendly consumables and energy-efficient instrumentation.

Taken together, these technological, regulatory, and sustainability-driven shifts are reshaping the competitive landscape, compelling traditional players to forge alliances with digital innovators and bioinformatics specialists. This convergence underscores the imperative for laboratories and service providers to embrace end-to-end digital transformation and partner with ecosystem collaborators to maintain strategic relevance.

Assessing the Comprehensive Cumulative Impact of 2025 United States Tariffs on Healthcare Analytical Testing Cost Structures and Operational Strategies

In 2025, the implementation of revised United States tariffs has introduced a new layer of complexity for healthcare analytical testing providers and their supply chains. Several key reagents, instrumentation components, and specialty consumables sourced from major manufacturing hubs have experienced incremental cost escalations. These adjustments have downstream effects on service pricing models, operating budgets, and capital expenditure plans for both single-site laboratories and multi-site networks. Furthermore, the ripple effects on global distributors have necessitated the reevaluation of inventory strategies to mitigate exposure to tariff fluctuations.

Laboratories reliant on imported chromatography columns, mass spectrometry source components, and specialty solvents have reported extended negotiation cycles with suppliers to secure favorable terms amidst ongoing trade tensions. To preserve margin integrity, many service providers have accelerated the adoption of domestic manufacturing partnerships and vetted alternative raw material sources. This strategic pivot not only offsets tariff burdens but also enhances supply chain resilience. In parallel, organizations have intensified their focus on lean laboratory principles, adopting modular instrumentation architectures and reagent pooling strategies to optimize resource utilization and contain costs without compromising performance.

The cumulative financial impact of the new tariff regime has also spurred dialogue between service providers, payer groups, and accreditation bodies regarding acceptable price adjustments and reimbursement frameworks. Stakeholders are exploring value-based contracting models that align reimbursement with demonstrable clinical outcomes, thereby cushioning laboratories against unsustainable price inflations. These collaborative efforts highlight the sector's capacity for adaptive resilience, as laboratories and service partners coalesce around innovative procurement and pricing mechanisms to ensure continuity of critical testing operations.

Revealing Insightful Key Segmentation Trends in Healthcare Analytical Testing Across Testing Types Technologies Samples Applications and End Users

Healthcare analytical testing can be understood through the prism of testing type, where qualitative services encompass spot tests designed for rapid visual or colorimetric responses alongside detailed visual inspection protocols that confirm sample integrity. In contrast, quantitative offerings rely on immunoassays to quantify biomarkers with high specificity and on instrumental analysis techniques that leverage spectroscopic signals and mass-to-charge ratios to deliver precise concentration measurements. This dual approach ensures both immediate screening capabilities and in-depth quantitative validation.

Examining the market through the lens of technology reveals an array of platforms, starting with chromatographic separation that differentiates analytes based on chemical properties and advances through gas and liquid chromatography modalities to achieve high-resolution results. Mass spectrometry further refines identification and quantitation by coupling gas chromatography with mass detectors, liquid chromatography with tandem mass spectrometry, or leveraging matrix-assisted laser desorption ionization for rapid profiling. Microscopy, polymerase chain reaction, and various spectroscopic techniques complement these core technologies, enabling multi-parameter analyses across diverse biological matrices.

Diverse sample types shape the testing workflow, with blood samples offering plasma, serum, or whole blood fractions to address immunological, metabolic, and hematological inquiries. Tissue biopsies and urine specimens provide insights into localized pathology and renal or metabolic function, respectively. Application-based segmentation underscores the multifaceted utility of analytical testing, spanning genetic sequencing for precision oncology, infectious disease panels for public health surveillance, forensic analysis for toxicology and DNA profiling, and stringent bioanalytical and quality control assays within pharmaceutical development.

End users range from research-focused academic and university laboratories to contract research organizations that offer specialized testing services. Hospital and pathology labs deliver critical diagnostic support in clinical settings, while pharmaceutical and biotechnology companies integrate analytical testing into drug discovery, formulation, and stability studies. This segmentation framework illuminates tailored service offerings, enabling stakeholders to align capabilities with distinct market needs and regulatory requirements.

Presenting Key Regional Insights into Healthcare Analytical Testing Market Variations Across the Americas Europe Middle East Africa and Asia Pacific

Regional dynamics play a pivotal role in shaping the global healthcare analytical testing landscape, as evolving regulatory frameworks, infrastructure capabilities, and investment patterns differ significantly across territories. In the Americas, established markets continue to refine reimbursement policies and incentivize the adoption of advanced diagnostic platforms, while emerging economies in Latin America are prioritizing laboratory capacity expansion and skill development to strengthen public health surveillance networks.

Across Europe, the Middle East, and Africa, regulatory harmonization efforts are accelerating the mutual recognition of testing standards, enabling cross-border collaboration and streamlining market entry for innovative assays. Investments in centralized reference laboratories and proficiency testing schemes are enhancing quality assurance, particularly in regions where decentralized sample collection must interface with urban testing hubs. Infrastructure upgrades, supported by public-private partnerships, are fostering the deployment of point-of-care testing and mobile laboratories to address remote populations.

The Asia-Pacific region continues to experience robust growth in analytical testing demand, driven by expanding biopharmaceutical research ecosystems, large-scale disease screening initiatives, and private sector laboratory consolidations. Government-led mandates are spurring capacity augmentation in metropolitan areas, while manufacturing clusters in key countries support the regional supply chain for instrumentation and consumables. Collaborative research consortia and cross-border knowledge sharing are further reinforcing quality standards and accelerating method development for emerging health threats.

These regional insights underscore the importance of adaptive strategies that respect local regulatory nuances, infrastructure readiness, and public health priorities. Service providers and equipment vendors must calibrate their offerings to align with the unique requirements of each region, fostering partnerships that address both urban centers of excellence and underserved populations.

Highlighting Strategic Movements and Competitive Landscapes of Leading Companies Driving Innovation in Healthcare Analytical Testing Services Globally

The competitive arena of healthcare analytical testing services is defined by a cohort of established laboratories, innovative service providers, and specialized technology vendors. Leading organizations are leveraging comprehensive service portfolios that integrate high-throughput screening, advanced bioinformatics, and customized assay development to differentiate themselves. Strategic investments in proprietary reagent kits, laboratory automation, and digital data platforms are enabling these pioneers to offer standardized yet flexible solutions that cater to a broad spectrum of clinical and research applications.

Mid-tier players are carving niches by focusing on specialized testing verticals such as rare disease panels, companion diagnostics, or forensic toxicology. These providers often form strategic alliances with academic institutions and biotechnology firms to co-develop assays and validate novel biomarkers. By concentrating on high-value testing segments, they are building reputational capital and fostering client loyalty through rapid turnaround times and dedicated technical support.

Emerging entrants, including digital health startups and specialty reagent manufacturers, are disrupting legacy models by introducing microfluidics-based point-of-care devices, AI-driven assay interpretation tools, and continuous monitoring platforms. These innovators are forging partnerships with traditional laboratories to integrate new capabilities, thereby accelerating adoption curves and expanding service reach. Additionally, several global reagent and consumables suppliers are deepening their service offerings by establishing in-house testing facilities, effectively transforming from product vendors to end-to-end service providers.

Competitive differentiation increasingly hinges on the ability to demonstrate value through data transparency, collaborative research frameworks, and flexible pricing constructs. As competitive pressures intensify, service providers that can seamlessly integrate advanced technologies, uphold rigorous quality standards, and foster collaborative ecosystems will emerge as industry frontrunners.

Providing Actionable Recommendations for Industry Leaders to Enhance Competitiveness and Drive Growth in Healthcare Analytical Testing Services

Industry leaders must prioritize investments in digital transformation to maintain competitive advantage and operational efficiency. Integrating cloud-based data management, artificial intelligence-enhanced analytics, and remote monitoring capabilities can drastically reduce turnaround times, enhance traceability, and support scalable laboratory networks. Cultivating partnerships with software developers and bioinformatics specialists will ensure that emerging technologies are seamlessly incorporated into existing workflows.

Laboratories and service providers should evaluate opportunities to diversify their reagent and consumables portfolio by establishing strategic sourcing agreements with multiple suppliers. This dual-sourcing strategy not only mitigates supply chain disruptions associated with trade tensions and regulatory changes but also fosters competitive pricing dynamics. Concurrently, organizations should conduct periodic spend analyses and lean process audits to eliminate waste, optimize reagent utilization, and enhance resource allocation across test volumes and types.

To navigate the evolving tariff landscape and reimbursement environment, stakeholders are advised to engage proactively with policymakers, payer groups, and accreditation bodies. Collaborative forums and value-based contracting frameworks can facilitate transparent dialogue on cost drivers, clinical outcomes, and mutual value creation. By aligning service pricing with demonstrable patient benefits and health economic outcomes, laboratories can secure sustainable reimbursement pathways and mitigate margin pressures.

Finally, fostering a culture of continuous learning and technical excellence remains imperative. Structured training programs, proficiency testing initiatives, and cross-functional knowledge exchanges will equip laboratory personnel and management teams to adapt swiftly to new analytical methods and regulatory guidelines. These actionable measures will position industry leaders to drive innovation, optimize profitability, and deliver superior testing services in a rapidly evolving healthcare landscape.

Detailing the Rigorous Research Methodology Employed for Comprehensive Analysis of Healthcare Analytical Testing Service Trends and Market Drivers

The research foundation for this analysis was established through a systematic multi-stage approach encompassing primary and secondary data acquisition, rigorous validation protocols, and expert consultations. Initially, an extensive literature review of peer-reviewed journals, regulatory guidelines, and industry white papers was conducted to map foundational trends and identify emerging technologies. This secondary research phase laid the groundwork for hypothesis generation and framework development.

Primary data collection involved in-depth interviews with a cross-section of industry stakeholders, including laboratory directors, technology vendors, regulatory specialists, and procurement managers. These conversations provided real-world insights into operational challenges, investment decision drivers, and strategic priorities. Additionally, surveys administered to service providers captured quantitative metrics related to technology adoption rates, capacity utilization, and cost management practices.

All collected data underwent a multi-tiered validation process, involving triangulation across sources, statistical consistency checks, and peer reviews by subject matter experts. Market intelligence tools were leveraged to analyze trade flows, tariff schedules, and regional infrastructure investments. The synthesis of qualitative narratives with quantitative indicators enabled the construction of a robust analytical model capable of delineating market dynamics and projecting strategic imperatives.

This rigorous methodology ensures that the findings presented herein are grounded in accurate, up-to-date evidence and reflect the nuanced realities of the healthcare analytical testing services sector. Stakeholders can thus engage with the insights confidently, knowing they are supported by a comprehensive and transparent research framework.

Synthesizing Critical Findings and Strategic Imperatives for Stakeholders Navigating the Evolving Healthcare Analytical Testing Services Environment

The confluence of technological innovation, regulatory evolution, and shifting economic pressures is reshaping the healthcare analytical testing services landscape. Stakeholders equipped with a clear understanding of transformative shifts-from advanced instrumentation adoption to the digitalization of data workflows-are positioned to capitalize on emerging opportunities and navigate market complexities. The 2025 tariff adjustments underscore the importance of resilient supply chains and collaborative procurement strategies to mitigate cost fluctuations and sustain margin integrity.

Segmentation insights reveal the critical interplay between qualitative and quantitative testing modalities, diversified technology platforms, and application-specific requirements across end users. Regional nuances further emphasize the need for tailored strategies that respect local regulatory frameworks while leveraging global best practices. Competitive dynamics highlight the rise of niche specialists and technology disruptors, reinforcing the imperative for continuous innovation and strategic partnerships.

By synthesizing these findings into actionable recommendations, industry leaders can prioritize investments in digital transformation, lean laboratory practices, and stakeholder engagement forums. This holistic perspective equips decision-makers with the tools to enhance operational efficiency, foster sustainable growth, and deliver high-value testing services that align with evolving clinical and research imperatives.

Ultimately, the insights presented in this summary will serve as a strategic compass, guiding laboratories, service providers, and technology partners toward informed decisions that drive long-term resilience and market leadership.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Market Sizing & Forecasting

5. Market Dynamics

  • 5.1. Integration of artificial intelligence and machine learning algorithms in clinical diagnostic testing to enhance accuracy and speed
  • 5.2. Adoption of point of care testing devices integrated with digital health ecosystems for real time patient monitoring
  • 5.3. Growth of personalized medicine driving demand for high throughput genomic and proteomic testing platforms
  • 5.4. Increasing regulatory emphasis on 21 CFR Part 11 compliance in laboratory information management systems
  • 5.5. Rising investment in metabolomics profiling for early disease biomarker discovery and preventive healthcare strategies
  • 5.6. Expansion of contract development and manufacturing organizations offering end to end analytical method development services
  • 5.7. Implementation of blockchain technology to ensure secure traceability of clinical trial samples and test results
  • 5.8. Surge in adoption of mass spectrometry imaging for spatial metabolomics and biomarker localization in tissue analysis
  • 5.9. Demand for multiomics data integration platforms to provide comprehensive insights across genomics proteomics and metabolomics datasets
  • 5.10. Focus on sustainability with development of green chemistry analytical methods to reduce hazardous reagent consumption

6. Market Insights

  • 6.1. Porter's Five Forces Analysis
  • 6.2. PESTLE Analysis

7. Cumulative Impact of United States Tariffs 2025

8. Healthcare Analytical Testing Services Market, by Testing Type

  • 8.1. Introduction
  • 8.2. Qualitative
    • 8.2.1. Spot Tests
    • 8.2.2. Visual Inspection
  • 8.3. Quantitative
    • 8.3.1. Immunoassays
    • 8.3.2. Instrumental Analysis

9. Healthcare Analytical Testing Services Market, by Technology Type

  • 9.1. Introduction
  • 9.2. Chromatography
    • 9.2.1. Gas Chromatography
    • 9.2.2. Liquid Chromatography
  • 9.3. Mass Spectrometry
    • 9.3.1. GC MS
    • 9.3.2. LC MS MS
    • 9.3.3. MALDI TOF
  • 9.4. Microscopy
  • 9.5. PCR
  • 9.6. Spectroscopy

10. Healthcare Analytical Testing Services Market, by Sample Type

  • 10.1. Introduction
  • 10.2. Blood
    • 10.2.1. Plasma
    • 10.2.2. Serum
    • 10.2.3. Whole Blood
  • 10.3. Tissue
  • 10.4. Urine

11. Healthcare Analytical Testing Services Market, by Application

  • 11.1. Introduction
  • 11.2. Clinical Diagnostics
    • 11.2.1. Genetic Testing
    • 11.2.2. Infectious Disease
    • 11.2.3. Oncology Markers
  • 11.3. Forensics Testing
    • 11.3.1. DNA Profiling
    • 11.3.2. Toxicology
  • 11.4. Pharmaceutical Testing
    • 11.4.1. Bioanalytical Testing
    • 11.4.2. Quality Control

12. Healthcare Analytical Testing Services Market, by End-User

  • 12.1. Introduction
  • 12.2. Academic & Research Institutes
    • 12.2.1. Research Institutes
    • 12.2.2. Universities
  • 12.3. Contract Research Organizations
  • 12.4. Hospitals & Clinics
    • 12.4.1. Hospital Labs
    • 12.4.2. Pathology Labs
  • 12.5. Pharmaceutical & Biotechnology Companies

13. Americas Healthcare Analytical Testing Services Market

  • 13.1. Introduction
  • 13.2. United States
  • 13.3. Canada
  • 13.4. Mexico
  • 13.5. Brazil
  • 13.6. Argentina

14. Europe, Middle East & Africa Healthcare Analytical Testing Services Market

  • 14.1. Introduction
  • 14.2. United Kingdom
  • 14.3. Germany
  • 14.4. France
  • 14.5. Russia
  • 14.6. Italy
  • 14.7. Spain
  • 14.8. United Arab Emirates
  • 14.9. Saudi Arabia
  • 14.10. South Africa
  • 14.11. Denmark
  • 14.12. Netherlands
  • 14.13. Qatar
  • 14.14. Finland
  • 14.15. Sweden
  • 14.16. Nigeria
  • 14.17. Egypt
  • 14.18. Turkey
  • 14.19. Israel
  • 14.20. Norway
  • 14.21. Poland
  • 14.22. Switzerland

15. Asia-Pacific Healthcare Analytical Testing Services Market

  • 15.1. Introduction
  • 15.2. China
  • 15.3. India
  • 15.4. Japan
  • 15.5. Australia
  • 15.6. South Korea
  • 15.7. Indonesia
  • 15.8. Thailand
  • 15.9. Philippines
  • 15.10. Malaysia
  • 15.11. Singapore
  • 15.12. Vietnam
  • 15.13. Taiwan

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2024
  • 16.2. FPNV Positioning Matrix, 2024
  • 16.3. Competitive Analysis
    • 16.3.1. Eurofins Scientific SE
    • 16.3.2. Laboratory Corporation of America Holdings
    • 16.3.3. Almac Group Limited
    • 16.3.4. ALS Limited
    • 16.3.5. Catalent, Inc.
    • 16.3.6. CD Biosciences Inc.
    • 16.3.7. Charles River Laboratories International, Inc.
    • 16.3.8. Element Materials Technology Group Limited
    • 16.3.9. Frontage Laboratories, Inc. by Tigermed
    • 16.3.10. ICON PLC
    • 16.3.11. Intertek Group PLC
    • 16.3.12. IQVIA Holdings Inc.
    • 16.3.13. Medpace, Inc.
    • 16.3.14. Pace Analytical Services, LLC
    • 16.3.15. Pharmaron
    • 16.3.16. Piramal Pharma Solutions
    • 16.3.17. PPD, Inc.
    • 16.3.18. Quest Diagnostics Incorporated
    • 16.3.19. Reading Scientific Services Ltd.
    • 16.3.20. Sartorius AG
    • 16.3.21. SGS SA
    • 16.3.22. Thermo Fisher Scientific Inc.
    • 16.3.23. WuXi AppTec Co., Ltd.

17. ResearchAI

18. ResearchStatistics

19. ResearchContacts

20. ResearchArticles

21. Appendix

LIST OF FIGURES

  • FIGURE 1. HEALTHCARE ANALYTICAL TESTING SERVICES MARKET RESEARCH PROCESS
  • FIGURE 2. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 3. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 4. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY TESTING TYPE, 2024 VS 2030 (%)
  • FIGURE 6. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY TESTING TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 7. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY TECHNOLOGY TYPE, 2024 VS 2030 (%)
  • FIGURE 8. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY TECHNOLOGY TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2030 (%)
  • FIGURE 10. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
  • FIGURE 12. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 13. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END-USER, 2024 VS 2030 (%)
  • FIGURE 14. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 15. AMERICAS HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 16. AMERICAS HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 17. UNITED STATES HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY STATE, 2024 VS 2030 (%)
  • FIGURE 18. UNITED STATES HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 21. ASIA-PACIFIC HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 22. ASIA-PACIFIC HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 23. HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 24. HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, FPNV POSITIONING MATRIX, 2024
  • FIGURE 25. HEALTHCARE ANALYTICAL TESTING SERVICES MARKET: RESEARCHAI
  • FIGURE 26. HEALTHCARE ANALYTICAL TESTING SERVICES MARKET: RESEARCHSTATISTICS
  • FIGURE 27. HEALTHCARE ANALYTICAL TESTING SERVICES MARKET: RESEARCHCONTACTS
  • FIGURE 28. HEALTHCARE ANALYTICAL TESTING SERVICES MARKET: RESEARCHARTICLES

LIST OF TABLES

  • TABLE 1. HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, 2025-2030 (USD MILLION)
  • TABLE 5. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 7. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 9. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY TESTING TYPE, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY TESTING TYPE, 2025-2030 (USD MILLION)
  • TABLE 11. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY QUALITATIVE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY QUALITATIVE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 13. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SPOT TESTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SPOT TESTS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 15. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY VISUAL INSPECTION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY VISUAL INSPECTION, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 17. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY QUALITATIVE, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY QUALITATIVE, 2025-2030 (USD MILLION)
  • TABLE 19. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY QUANTITATIVE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY QUANTITATIVE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 21. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY IMMUNOASSAYS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY IMMUNOASSAYS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 23. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY INSTRUMENTAL ANALYSIS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY INSTRUMENTAL ANALYSIS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 25. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY QUANTITATIVE, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY QUANTITATIVE, 2025-2030 (USD MILLION)
  • TABLE 27. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY TECHNOLOGY TYPE, 2025-2030 (USD MILLION)
  • TABLE 29. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY CHROMATOGRAPHY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY CHROMATOGRAPHY, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 31. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY GAS CHROMATOGRAPHY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY GAS CHROMATOGRAPHY, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 33. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY LIQUID CHROMATOGRAPHY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY LIQUID CHROMATOGRAPHY, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 35. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY CHROMATOGRAPHY, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY CHROMATOGRAPHY, 2025-2030 (USD MILLION)
  • TABLE 37. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY MASS SPECTROMETRY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY MASS SPECTROMETRY, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 39. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY GC MS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY GC MS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 41. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY LC MS MS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY LC MS MS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 43. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY MALDI TOF, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY MALDI TOF, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 45. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY MASS SPECTROMETRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY MASS SPECTROMETRY, 2025-2030 (USD MILLION)
  • TABLE 47. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY MICROSCOPY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY MICROSCOPY, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 49. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY PCR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY PCR, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 51. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SPECTROSCOPY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SPECTROSCOPY, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 53. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
  • TABLE 55. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY BLOOD, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY BLOOD, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 57. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY PLASMA, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY PLASMA, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 59. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SERUM, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SERUM, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 61. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY WHOLE BLOOD, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY WHOLE BLOOD, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 63. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY BLOOD, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY BLOOD, 2025-2030 (USD MILLION)
  • TABLE 65. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY TISSUE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY TISSUE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 67. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY URINE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY URINE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 69. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 71. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 73. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY GENETIC TESTING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY GENETIC TESTING, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 75. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY INFECTIOUS DISEASE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY INFECTIOUS DISEASE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 77. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY ONCOLOGY MARKERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY ONCOLOGY MARKERS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 79. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2030 (USD MILLION)
  • TABLE 81. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY FORENSICS TESTING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY FORENSICS TESTING, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 83. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY DNA PROFILING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY DNA PROFILING, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 85. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY TOXICOLOGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY TOXICOLOGY, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 87. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY FORENSICS TESTING, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY FORENSICS TESTING, 2025-2030 (USD MILLION)
  • TABLE 89. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY PHARMACEUTICAL TESTING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY PHARMACEUTICAL TESTING, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 91. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY BIOANALYTICAL TESTING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY BIOANALYTICAL TESTING, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 93. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY QUALITY CONTROL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY QUALITY CONTROL, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 95. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY PHARMACEUTICAL TESTING, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY PHARMACEUTICAL TESTING, 2025-2030 (USD MILLION)
  • TABLE 97. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
  • TABLE 99. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 101. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 103. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY UNIVERSITIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY UNIVERSITIES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 105. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
  • TABLE 107. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 109. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 111. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY HOSPITAL LABS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY HOSPITAL LABS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 113. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY PATHOLOGY LABS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY PATHOLOGY LABS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 115. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY HOSPITALS & CLINICS, 2025-2030 (USD MILLION)
  • TABLE 117. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 119. AMERICAS HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY TESTING TYPE, 2018-2024 (USD MILLION)
  • TABLE 120. AMERICAS HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY TESTING TYPE, 2025-2030 (USD MILLION)
  • TABLE 121. AMERICAS HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY QUALITATIVE, 2018-2024 (USD MILLION)
  • TABLE 122. AMERICAS HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY QUALITATIVE, 2025-2030 (USD MILLION)
  • TABLE 123. AMERICAS HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY QUANTITATIVE, 2018-2024 (USD MILLION)
  • TABLE 124. AMERICAS HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY QUANTITATIVE, 2025-2030 (USD MILLION)
  • TABLE 125. AMERICAS HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2024 (USD MILLION)
  • TABLE 126. AMERICAS HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY TECHNOLOGY TYPE, 2025-2030 (USD MILLION)
  • TABLE 127. AMERICAS HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY CHROMATOGRAPHY, 2018-2024 (USD MILLION)
  • TABLE 128. AMERICAS HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY CHROMATOGRAPHY, 2025-2030 (USD MILLION)
  • TABLE 129. AMERICAS HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY MASS SPECTROMETRY, 2018-2024 (USD MILLION)
  • TABLE 130. AMERICAS HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY MASS SPECTROMETRY, 2025-2030 (USD MILLION)
  • TABLE 131. AMERICAS HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
  • TABLE 132. AMERICAS HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
  • TABLE 133. AMERICAS HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY BLOOD, 2018-2024 (USD MILLION)
  • TABLE 134. AMERICAS HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY BLOOD, 2025-2030 (USD MILLION)
  • TABLE 135. AMERICAS HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 136. AMERICAS HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 137. AMERICAS HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 138. AMERICAS HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2030 (USD MILLION)
  • TABLE 139. AMERICAS HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY FORENSICS TESTING, 2018-2024 (USD MILLION)
  • TABLE 140. AMERICAS HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY FORENSICS TESTING, 2025-2030 (USD MILLION)
  • TABLE 141. AMERICAS HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY PHARMACEUTICAL TESTING, 2018-2024 (USD MILLION)
  • TABLE 142. AMERICAS HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY PHARMACEUTICAL TESTING, 2025-2030 (USD MILLION)
  • TABLE 143. AMERICAS HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 144. AMERICAS HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
  • TABLE 145. AMERICAS HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
  • TABLE 146. AMERICAS HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
  • TABLE 147. AMERICAS HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2024 (USD MILLION)
  • TABLE 148. AMERICAS HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY HOSPITALS & CLINICS, 2025-2030 (USD MILLION)
  • TABLE 149. AMERICAS HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 150. AMERICAS HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 151. UNITED STATES HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY TESTING TYPE, 2018-2024 (USD MILLION)
  • TABLE 152. UNITED STATES HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY TESTING TYPE, 2025-2030 (USD MILLION)
  • TABLE 153. UNITED STATES HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY QUALITATIVE, 2018-2024 (USD MILLION)
  • TABLE 154. UNITED STATES HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY QUALITATIVE, 2025-2030 (USD MILLION)
  • TABLE 155. UNITED STATES HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY QUANTITATIVE, 2018-2024 (USD MILLION)
  • TABLE 156. UNITED STATES HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY QUANTITATIVE, 2025-2030 (USD MILLION)
  • TABLE 157. UNITED STATES HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2024 (USD MILLION)
  • TABLE 158. UNITED STATES HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY TECHNOLOGY TYPE, 2025-2030 (USD MILLION)
  • TABLE 159. UNITED STATES HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY CHROMATOGRAPHY, 2018-2024 (USD MILLION)
  • TABLE 160. UNITED STATES HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY CHROMATOGRAPHY, 2025-2030 (USD MILLION)
  • TABLE 161. UNITED STATES HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY MASS SPECTROMETRY, 2018-2024 (USD MILLION)
  • TABLE 162. UNITED STATES HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY MASS SPECTROMETRY, 2025-2030 (USD MILLION)
  • TABLE 163. UNITED STATES HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
  • TABLE 164. UNITED STATES HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
  • TABLE 165. UNITED STATES HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY BLOOD, 2018-2024 (USD MILLION)
  • TABLE 166. UNITED STATES HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY BLOOD, 2025-2030 (USD MILLION)
  • TABLE 167. UNITED STATES HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 168. UNITED STATES HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 169. UNITED STATES HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 170. UNITED STATES HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2030 (USD MILLION)
  • TABLE 171. UNITED STATES HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY FORENSICS TESTING, 2018-2024 (USD MILLION)
  • TABLE 172. UNITED STATES HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY FORENSICS TESTING, 2025-2030 (USD MILLION)
  • TABLE 173. UNITED STATES HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY PHARMACEUTICAL TESTING, 2018-2024 (USD MILLION)
  • TABLE 174. UNITED STATES HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY PHARMACEUTICAL TESTING, 2025-2030 (USD MILLION)
  • TABLE 175. UNITED STATES HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 176. UNITED STATES HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
  • TABLE 177. UNITED STATES HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
  • TABLE 178. UNITED STATES HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
  • TABLE 179. UNITED STATES HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2024 (USD MILLION)
  • TABLE 180. UNITED STATES HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY HOSPITALS & CLINICS, 2025-2030 (USD MILLION)
  • TABLE 181. UNITED STATES HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
  • TABLE 182. UNITED STATES HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
  • TABLE 183. CANADA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY TESTING TYPE, 2018-2024 (USD MILLION)
  • TABLE 184. CANADA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY TESTING TYPE, 2025-2030 (USD MILLION)
  • TABLE 185. CANADA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY QUALITATIVE, 2018-2024 (USD MILLION)
  • TABLE 186. CANADA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY QUALITATIVE, 2025-2030 (USD MILLION)
  • TABLE 187. CANADA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY QUANTITATIVE, 2018-2024 (USD MILLION)
  • TABLE 188. CANADA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY QUANTITATIVE, 2025-2030 (USD MILLION)
  • TABLE 189. CANADA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2024 (USD MILLION)
  • TABLE 190. CANADA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY TECHNOLOGY TYPE, 2025-2030 (USD MILLION)
  • TABLE 191. CANADA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY CHROMATOGRAPHY, 2018-2024 (USD MILLION)
  • TABLE 192. CANADA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY CHROMATOGRAPHY, 2025-2030 (USD MILLION)
  • TABLE 193. CANADA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY MASS SPECTROMETRY, 2018-2024 (USD MILLION)
  • TABLE 194. CANADA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY MASS SPECTROMETRY, 2025-2030 (USD MILLION)
  • TABLE 195. CANADA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
  • TABLE 196. CANADA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
  • TABLE 197. CANADA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY BLOOD, 2018-2024 (USD MILLION)
  • TABLE 198. CANADA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY BLOOD, 2025-2030 (USD MILLION)
  • TABLE 199. CANADA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 200. CANADA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 201. CANADA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 202. CANADA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2030 (USD MILLION)
  • TABLE 203. CANADA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY FORENSICS TESTING, 2018-2024 (USD MILLION)
  • TABLE 204. CANADA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY FORENSICS TESTING, 2025-2030 (USD MILLION)
  • TABLE 205. CANADA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY PHARMACEUTICAL TESTING, 2018-2024 (USD MILLION)
  • TABLE 206. CANADA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY PHARMACEUTICAL TESTING, 2025-2030 (USD MILLION)
  • TABLE 207. CANADA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 208. CANADA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
  • TABLE 209. CANADA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
  • TABLE 210. CANADA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
  • TABLE 211. CANADA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2024 (USD MILLION)
  • TABLE 212. CANADA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY HOSPITALS & CLINICS, 2025-2030 (USD MILLION)
  • TABLE 213. MEXICO HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY TESTING TYPE, 2018-2024 (USD MILLION)
  • TABLE 214. MEXICO HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY TESTING TYPE, 2025-2030 (USD MILLION)
  • TABLE 215. MEXICO HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY QUALITATIVE, 2018-2024 (USD MILLION)
  • TABLE 216. MEXICO HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY QUALITATIVE, 2025-2030 (USD MILLION)
  • TABLE 217. MEXICO HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY QUANTITATIVE, 2018-2024 (USD MILLION)
  • TABLE 218. MEXICO HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY QUANTITATIVE, 2025-2030 (USD MILLION)
  • TABLE 219. MEXICO HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2024 (USD MILLION)
  • TABLE 220. MEXICO HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY TECHNOLOGY TYPE, 2025-2030 (USD MILLION)
  • TABLE 221. MEXICO HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY CHROMATOGRAPHY, 2018-2024 (USD MILLION)
  • TABLE 222. MEXICO HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY CHROMATOGRAPHY, 2025-2030 (USD MILLION)
  • TABLE 223. MEXICO HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY MASS SPECTROMETRY, 2018-2024 (USD MILLION)
  • TABLE 224. MEXICO HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY MASS SPECTROMETRY, 2025-2030 (USD MILLION)
  • TABLE 225. MEXICO HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
  • TABLE 226. MEXICO HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
  • TABLE 227. MEXICO HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY BLOOD, 2018-2024 (USD MILLION)
  • TABLE 228. MEXICO HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY BLOOD, 2025-2030 (USD MILLION)
  • TABLE 229. MEXICO HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 230. MEXICO HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 231. MEXICO HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 232. MEXICO HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2030 (USD MILLION)
  • TABLE 233. MEXICO HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY FORENSICS TESTING, 2018-2024 (USD MILLION)
  • TABLE 234. MEXICO HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY FORENSICS TESTING, 2025-2030 (USD MILLION)
  • TABLE 235. MEXICO HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY PHARMACEUTICAL TESTING, 2018-2024 (USD MILLION)
  • TABLE 236. MEXICO HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY PHARMACEUTICAL TESTING, 2025-2030 (USD MILLION)
  • TABLE 237. MEXICO HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 238. MEXICO HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
  • TABLE 239. MEXICO HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
  • TABLE 240. MEXICO HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
  • TABLE 241. MEXICO HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2024 (USD MILLION)
  • TABLE 242. MEXICO HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY HOSPITALS & CLINICS, 2025-2030 (USD MILLION)
  • TABLE 243. BRAZIL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY TESTING TYPE, 2018-2024 (USD MILLION)
  • TABLE 244. BRAZIL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY TESTING TYPE, 2025-2030 (USD MILLION)
  • TABLE 245. BRAZIL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY QUALITATIVE, 2018-2024 (USD MILLION)
  • TABLE 246. BRAZIL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY QUALITATIVE, 2025-2030 (USD MILLION)
  • TABLE 247. BRAZIL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY QUANTITATIVE, 2018-2024 (USD MILLION)
  • TABLE 248. BRAZIL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY QUANTITATIVE, 2025-2030 (USD MILLION)
  • TABLE 249. BRAZIL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2024 (USD MILLION)
  • TABLE 250. BRAZIL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY TECHNOLOGY TYPE, 2025-2030 (USD MILLION)
  • TABLE 251. BRAZIL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY CHROMATOGRAPHY, 2018-2024 (USD MILLION)
  • TABLE 252. BRAZIL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY CHROMATOGRAPHY, 2025-2030 (USD MILLION)
  • TABLE 253. BRAZIL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY MASS SPECTROMETRY, 2018-2024 (USD MILLION)
  • TABLE 254. BRAZIL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY MASS SPECTROMETRY, 2025-2030 (USD MILLION)
  • TABLE 255. BRAZIL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
  • TABLE 256. BRAZIL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
  • TABLE 257. BRAZIL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY BLOOD, 2018-2024 (USD MILLION)
  • TABLE 258. BRAZIL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY BLOOD, 2025-2030 (USD MILLION)
  • TABLE 259. BRAZIL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 260. BRAZIL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 261. BRAZIL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 262. BRAZIL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2030 (USD MILLION)
  • TABLE 263. BRAZIL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY FORENSICS TESTING, 2018-2024 (USD MILLION)
  • TABLE 264. BRAZIL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY FORENSICS TESTING, 2025-2030 (USD MILLION)
  • TABLE 265. BRAZIL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY PHARMACEUTICAL TESTING, 2018-2024 (USD MILLION)
  • TABLE 266. BRAZIL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY PHARMACEUTICAL TESTING, 2025-2030 (USD MILLION)
  • TABLE 267. BRAZIL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 268. BRAZIL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
  • TABLE 269. BRAZIL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
  • TABLE 270. BRAZIL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
  • TABLE 271. BRAZIL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2024 (USD MILLION)
  • TABLE 272. BRAZIL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY HOSPITALS & CLINICS, 2025-2030 (USD MILLION)
  • TABLE 273. ARGENTINA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY TESTING TYPE, 2018-2024 (USD MILLION)
  • TABLE 274. ARGENTINA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY TESTING TYPE, 2025-2030 (USD MILLION)
  • TABLE 275. ARGENTINA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY QUALITATIVE, 2018-2024 (USD MILLION)
  • TABLE 276. ARGENTINA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY QUALITATIVE, 2025-2030 (USD MILLION)
  • TABLE 277. ARGENTINA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY QUANTITATIVE, 2018-2024 (USD MILLION)
  • TABLE 278. ARGENTINA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY QUANTITATIVE, 2025-2030 (USD MILLION)
  • TABLE 279. ARGENTINA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2024 (USD MILLION)
  • TABLE 280. ARGENTINA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY TECHNOLOGY TYPE, 2025-2030 (USD MILLION)
  • TABLE 281. ARGENTINA HEALTH